Migraine’s Link to Hearing and Sound Disorders

A systemic disorder of multisensory sensitization, migraine is far more than a headache. New evidence confirms that auditory symptoms like hearing loss, tinnitus, and hyperacusis are not just occasional companions but are central features of the migraine spectrum. A 2026 review published in the *Journal of Neurology* synthesizes data revealing that 15% to 49% of migraine patients experience these comorbid auditory issues, with nearly two-thirds showing electrophysiological abnormalities in their auditory pathways.

How the Research Connects Migraine and Hearing

Led by researchers including Wandi Xu, Ni Zhai, and Jingyu Chen, this review did not conduct new experiments. Instead, the team analyzed and synthesized decades of existing epidemiological, audiological, and pathophysiological research. Their methodology involved compiling data from clinical studies and basic science to build a cohesive model explaining why auditory dysfunction is so prevalent in migraine. This approach allows for a broad, evidence-based perspective on the link, moving beyond simply noting the co-occurrence of symptoms to explaining the underlying biological mechanisms.

A Three-Axis Model: From Ear to Brain

The central finding of the review is a proposed “peripheral-to-central continuum” model. The authors argue that auditory dysfunction in migraine is not caused by a single problem, but by disruptions across three interacting biological axes.

First, anatomical and hydrodynamic vulnerabilities can lead to localized microvascular ischemia in the inner ear and disrupt the delicate exchange of brain-ear fluids. This creates a fragile environment for the sensory cells of the cochlea.

Second, localized neurochemical imbalances directly disrupt inner ear homeostasis. The review points to glutamate excitotoxicity—where an overabundance of this excitatory neurotransmitter damages cells—along with dysregulated neuropeptide signaling and activation of the innate immune system within the cochlea.

Third, and perhaps most significant for conditions like tinnitus and hyperacusis, is the role of central sensitization. The migraine brain exhibits heightened sensitivity and altered plasticity in neural networks. This manifests as impaired efferent gating, where the brain’s ability to filter out irrelevant auditory signals fails, and thalamocortical dysrhythmia, where rhythmic brainwave patterns become disordered. These central changes can amplify sound perception and generate phantom noises like tinnitus. This concept of central network dysfunction is also explored in our article on the shared neurobiology of PTSD and tinnitus.

Implications for Diagnosis and Clinical Management

The high prevalence of auditory issues—present in up to half of migraine patients—means that hearing health should be a standard part of migraine assessment. The authors note that variable audiological protocols and a lack of awareness often lead to these symptoms being overlooked. For patients with migraine who report ringing in the ears, sound sensitivity, or hearing changes, this research validates their experience as a likely component of their neurological condition, not an unrelated problem.

This integrated view supports the need for cross-disciplinary care. Effective management may require collaboration between neurologists, otolaryngologists, and audiologists. Understanding the specific axis of dysfunction (vascular, cochlear, or central) in a given patient could lead to more precise treatment. For instance, a patient whose primary issue is central hypersensitivity may benefit from different strategies than one with clear cochlear microvascular compromise.

From Mechanism to Treatment: A Targeted Framework

Building on their three-axis model, Xu, Zhai, Chen, and colleagues propose a structured framework for therapy. Current and emerging treatments can be categorized by their specific clinical objective rather than a one-size-fits-all approach.

1. Blocking Upstream Migraine Pathways: This includes standard migraine prophylactic and acute medications that may indirectly improve auditory symptoms by calming the overall sensitized state of the nervous system.

2. Protecting the Cochlear Microenvironment: Strategies here aim to shield the inner ear from the vascular and neurochemical insults described. This could involve investigating agents that reduce glutamate excitotoxicity or support inner ear blood flow.

3. Correcting Central Hypersensitivity: This is directly relevant for tinnitus and hyperacusis. Treatments might include neuromodulation approaches that aim to retrain dysfunctional brain networks. The review’s focus on central pathways aligns with research into other neuromodulation techniques, such as vagus nerve stimulation for tinnitus relief. Furthermore, the principle of managing a hypersensitive auditory system is central to managing misophonia in teens and young adults.

Why This Synthesis Matters for Patients

This research, detailed in the review (PMID: 42371148), moves the conversation from correlation to causation. It provides a scientifically plausible explanation for why migraine and auditory disorders are so frequently linked. For patients, this means their auditory symptoms are likely a core part of their migraine biology, not a random coincidence. It argues for comprehensive care that addresses the entire sensory system. The proposed treatment framework offers a roadmap for future clinical trials to test targeted therapies, moving toward a future where management is based on the specific underlying mechanism affecting each individual.